Soligenix announces recent accomplishments and year end 2024 financial results

Princeton, n.j. , march 21, 2025 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the year ended december 31, 2024.
SNGX Ratings Summary
SNGX Quant Ranking